首站-论文投稿智能助手
典型文献
Pure drug nano-assemblies:A facile carrier-free nanoplatform for efficient cancer therapy
文献摘要:
Nanoparticulate drug delivery systems(Nano-DDSs)have emerged as possible solution to the obstacles of anticancer drug delivery.However,the clinical outcomes and translation are restricted by several drawbacks,such as low drug loading,premature drug leakage and carrier-related toxicity.Recently,pure drug nano-assemblies(PDNAs),fabricated by the self-assembly or co-assembly of pure drug molecules,have attracted considerable attention.Their facile and reproducible preparation technique helps to remove the bottleneck of nanomedicines including quality control,scale-up production and clin-ical translation.Acting as both carriers and cargos,the carrier-free PDNAs have an ultra-high or even 100%drug loading.In addition,combination therapies based on PDNAs could possibly address the most intractable problems in cancer treatment,such as tumor metastasis and drug resistance.In the present re-view,the latest development of PDNAs for cancer treatment is overviewed.First,PDNAs are classified according to the composition of drug molecules,and the assembly mechanisms are discussed.Further-more,the co-delivery of PDNAs for combination therapies is summarized,with special focus on the improvement of therapeutic outcomes.Finally,future prospects and challenges of PDNAs for efficient cancer therapy are spotlighted.
文献关键词:
作者姓名:
Shuwen Fu;Guanting Li;Wenli Zang;Xinyu Zhou;Kexin Shi;Yinglei Zhai
作者机构:
School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China;Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China;Department of Periodontology,School and Hospital of Stomatology,China Medical University,Liaoning Provincial Key Laboratory of Oral Disease,Shenyang 110016,China;Bio-system Pharmacology,Graduate School of Medicine,Faculty of Medicine,Osaka University,Osaka 565-0871,Japan;Department of Biomedical Engineering,School of Medical Device,Shenyang Pharmaceutical University,Shenyang 110016,China
引用格式:
[1]Shuwen Fu;Guanting Li;Wenli Zang;Xinyu Zhou;Kexin Shi;Yinglei Zhai-.Pure drug nano-assemblies:A facile carrier-free nanoplatform for efficient cancer therapy)[J].药学学报(英文版),2022(01):92-106
A类:
Nanoparticulate,DDSs,PDNAs,spotlighted
B类:
Pure,drug,assemblies,facile,free,nanoplatform,efficient,therapy,delivery,systems,have,emerged,possible,solution,obstacles,anticancer,However,clinical,outcomes,translation,are,restricted,by,several,drawbacks,such,low,loading,premature,leakage,related,toxicity,Recently,pure,fabricated,self,assembly,molecules,attracted,considerable,attention,Their,reproducible,preparation,technique,helps,remove,bottleneck,nanomedicines,including,quality,control,scale,up,production,Acting,both,carriers,cargos,ultra,high,even,In,addition,combination,therapies,could,possibly,address,most,intractable,problems,treatment,tumor,metastasis,resistance,present,latest,development,overviewed,First,classified,according,composition,mechanisms,discussed,Further,more,summarized,special,focus,improvement,therapeutic,Finally,future,prospects,challenges
AB值:
0.512471
相似文献
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。